A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19

Data Availability
Plan to Share Individual Participant Data (IPD): Yes Plan Description: All of the individual participant data collected during the trial, after deidentification. Supporting Materials: Study Protocol Supporting Materials: Statistical Analysis Plan (SAP) Supporting Materials: Informed Consent Form (ICF) Supporting Materials: Clinical Study Report (CSR) Supporting Materials: Analytic Code Time Frame: Beginning 3 months and ending 5 years following article publication. Email addresses hramos{at}unicah.edu; hmramos{at}uc.cl Access Criteria: Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For individual participant data meta-analysis.
Subject Area
- Addiction Medicine (213)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1090)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9741)
- Gastroenterology (480)
- Genetic and Genomic Medicine (2298)
- Geriatric Medicine (221)
- Health Economics (461)
- Health Informatics (1546)
- Health Policy (729)
- Hematology (236)
- HIV/AIDS (499)
- Medical Education (236)
- Medical Ethics (67)
- Nephrology (256)
- Neurology (2136)
- Nursing (133)
- Nutrition (332)
- Oncology (1171)
- Ophthalmology (363)
- Orthopedics (128)
- Otolaryngology (220)
- Pain Medicine (144)
- Palliative Medicine (49)
- Pathology (308)
- Pediatrics (690)
- Primary Care Research (265)
- Public and Global Health (4640)
- Radiology and Imaging (775)
- Respiratory Medicine (620)
- Rheumatology (273)
- Sports Medicine (208)
- Surgery (250)
- Toxicology (42)
- Transplantation (120)
- Urology (94)